Magnesium is the fourth most abundant cation in the body.
It is important in over 300 reactions in the body. The recommended daily intake of magnesium is310 to 420 mgday i . In !merica " #$% are deficient ii
Metabolic Syndrome Metabolic &yndrome is characteri'ed as group of risk factors (hich increases the risk for coronary heart disease" stroke and peripheral vascular disease. These risk factors are " hypertension, diabetes, hyperlipidemia and a pro-inflammatory state. Hypertension Magnesium (as first recommended as a therapy of malignant hypertension as early as 1)2* iii . +igh blood pressure has been sho(n to cause endothelial damage (hich leads to atherosclerosis. ,esearch has sho( there is a change in vascular smooth muscle tone (ith changes in magnesium. This change is due to magnesium controlling the intracellular deposition of calcium. In cases (here magnesium is lo( there (ill be an increase in vascular smooth muscle tone. This results in an increases in peripheral vascular resistance (hich leads to increased blood pressure. -ne study found a decrease in both systolic and diastolic pressure by an average of 12$ mm+g. !ffects seem to occur (ith doses bet(een #00 and 1000mg iv . Intracellular free magnesium in erythrocytes of essential hypertension: Relation to blood pressure and serum divalent cations Resnick LM, Gupta RK and Laragh JH Proc. Natl. Acad. Sci., 1!"# $ol !%&cto'er() *+11,*+1+. Obective: To investigate if hypertension is linked to abnormalities of intracellular free magnesium or total serum magnesium levels .free / e0tracellular1 Subects: +ypertensive untreated .+i2314 11 5ormotensive on therapy .+i236,014 $ +ypertensive no medical treatment .5714 8 Method: 2lood pressure (as taken and peripheral venous blood (as dra(n after a night of fasting. &erum magnesium levels (ere measured using an autoanaly'er. Intracellular free magnesium (as measured using an 5M, spectrometer. 9alculations (ere used to determine the free magnesium using the information from the 5M, spectra. Results: Modified from table 1 Group BP (mmHG) Total Mg meq/L Free Mg uM 57 12$:$84:3 1.)2:0.04 2#1:).$ +i23 1#*:8102:3; 1.$2:0.04 1)2:$.0; +i236,0 1*0:$$3:1 1.$):0.04 238:8.$ ; significance level4 0.001 vs. normotensive +igh blood pressure (ith no treatment has the lo(est magnesium intracellular free magnesium 5o difference in total Mg &ystolic correlated negatively (ith intracellular free Mg <iastolic correlated even more strongly inversely (ith intracellular free Mg. !onclusion: Those (ith lo(er free magnesium (ould be associated (ith higher intracellular free calcium and thus be associated proportionally (ith higher blood pressures. Hyperlipidemia"Hypercholesterolemia +igh levels of lipoproteins have been sho(n to cause damage to endothelial (alls. This causes an increase in calcium ion permeability" invasion of macrophages and alterations in smooth muscle cells causes atherosclerosis v 7o( levels of magnesium have been sho(n to enhance the development of atherogenic lesions and have been linked to a decrease in cholesterol and triglycerides in normal .2*63*%1 as (ell as atherosclerotic .20640%1 animals vi . #therogenic lipid fractions are related to ioni$ed magnesium status +aenni" !+" -hrvall M = 7ithell" +. !m > 9lin 5utr" 1))$? #8420268. Obective: To investigate the associations bet(een variables reflecting lipid and glucose metabolism and ioni'ed magnesium .iMg1 and serum total magnesium .tMg1 concentrations Subects: 2) &(edish men (ith mean age 82.* years (ith impaired insulin sensitivity. T(o .21 (ere on beta blockers and t(o .21 (ere on diuretics. Three .31 (ere smokers. Methods: The study measured tricylglycerol cholesterol concentrations" @7<7" 7<7" +<7" serum fatty acids" apolipoproteins" plasma iMg and tMA. !n intravenous glucose tolerance test (as performed. 3lasma insulin concentrations" glucose uptake" and plasma glucose (ere also measured. Results: iMg (as inversely correlated (ith4 @7<7 7<7 7<74+<7 Total cholesterol @7<l tricacylglycerol Total triacylglycerol tMg tended to inversely correlated (ith the above but not significant. 2oth" iMg and tMg" (ere not correlated (ith +<7 5ote4 There (as also noted a correlation (ith insulin increment and the area under the curve during an intravenous glucose tolerance test (ere inversely correlated (ith iMg but not tMg. !onclusion: atherogenic lipid fractions are more closely associated (ith concentration of plasma iMg than serum tMg. %ro-inflammatory state Metabolic syndrome predisposes an individual to cardiovascular disease and type II diabetes among other things. -ne of the conditions for metabolic syndrome that increases risk of these diseases is a pro6inflammatory state. ,ecent advances
in basic science have established a fundamental role for inflammation
in mediating all stages of atherosclerosis from initiation through
progression and" ultimately" the thrombotic complications of
atherosclerosis. vii It is kno(n that lo(6grade inflammation precedes and predicts
diabetes development in adults. viii The current state of inflammation in the body can be measured by the level of 96reactive protein in the blood. 96reactive protein is a cytokine of the immune system made in the liver. 3eople (ith the metabolic syndrome are more likely to have elevated 96reactive protein levels. ! study done by B.&ong and colleagues found that (omen (ho had more magnesium in their diets had lo(er levels of 96reactive protein. i0 The study also found that these (omen (ere less likely to have the metabolic syndrome and heart and blood vessel disease. 0 It is important to note that this study used magnesium levels that (ere present in the diet" so it is not safe to assume that supplemental magnesium (ould have the same effect. !lso" it is possible that something in the diet other than magnesium (as responsible for the findings. Relationship bet&een serum magnesium levels and !-reactive protein concentration, non-diabetic, non-hypertensive obese subects. Auerrero6,omero C" ,odriDue'6Moran M. International >ournal of -besity. 2002? @ol.2#4 4#)6484. Obective: To e0amine the relationship bet(een serum magnesium and 96reactive protein in non6diabetic" non6hypertensive obese subEects. Subects: There (ere 318 subEects" 101 (ere men and 280 (ere (omen. 13$ (ere lean" 133 (ere over (eight and 100 (ere obese. 3regnancy" alcohol consumption" cigarette smoking" diabetes" high blood pressure" cardiovascular disease" coronary heart disease" renal disease" chronic disorders of the Eoints and connective tissue" acute infectious disease and malignancy (ere e0clusion criteria. Measurements: ! 8*g oral glucose load after 10 hours overnight fasting (as performed. 2lood samples (ere taken before and 2 hours after the glucose load. &erum glucose (as measured. 7ipid profiles (ere measured. 96reactive protein concentration (as also measured. &erum magnesium concentrations (ere measured by colorimetric method. Results: The lo(est levels of magnesium (ere found in the obese subEects.. $2.1% of those (ith lo( serum magnesium concentrations .* over(eight and 1$ obese1 had c6reactive protein concentrations higher than 10mgl. !onclusion: There is a relationship bet(een lo( serum magnesium concentrations and high c6reactive proteins in non6hypertensive" non6diabetic obese subEects. i Fing <G" Mainous !A" Aeesey MG = Hooson ,C. <ietary magnesium and c6reactive protein levels. >ournal of the !merican 9ollege of 5utrition. 200*? @ol.314 1##6181. ii Fing <G" Mainous !A" Aeesey MG = Hooson ,C. <ietary magnesium and c6reactive protein levels. >ournal of the !merican 9ollege of 5utrition. 200*? @ol.314 1##6181. iii ,esnick 7M" Aupta ,F" 7aragh >+. Intracellular free magnesium in erthyrocytes of essential hypertension4 ,elation to blood pressure and serum divalent cations. 3roc. 5atl. !cad. &ci." 1)$4? @ol $.-ctober14 #*116#*1*. iv Magnesium. (((.naturaldatabase.com v !ltura 2T" 2rust M" 2loom &" 2arbour ,7" &tempak >A = !ltura 2M. Magnesium dietary intake modulates blood lipid levels and atherogensis. 3roc. 5atl. !cad. &ci I&!" 1))0? @ol $8.March14 1$4061$44. vi !ltura 2T" 2rust M" 2loom &" 2arbour ,7" &tempak >A = !ltura 2M. Magnesium dietary intake modulates blood lipid levels and atherogensis. 3roc. 5atl. !cad. &ci I&!" 1))0? @ol $8.March14 1$4061$44. vii 7ibby 3" Maseri !" ,idker 3. Inflammation and !therosclerosis. -irculation. 2002? 10*4113*. viii &chmidt MI" <uncan 22" &harrett !," 7indberg A" &avage 3>" -ffenbacher &" !'ambuEa MI" Tracy ,3" +eiss A. Markers of inflammation and prediction of diabetes mellitus in adults .!therosclerosis ,isk in 9ommunities &tudy14 a cohort study. 7ancet. 1)))? 3*3 41#4) J1#*2. i0 &ong B" and colleagues. Magnesium intake" 96reactive protein" and the prevalence of metabolic syndrome in middle aged and older I.&. (omen. <iabetes 9are. 200*? 2$4143$61444. 0 &ong B" and colleagues. Magnesium intake" 96reactive protein" and the prevalence of metabolic syndrome in middle aged and older I.&. (omen. <iabetes 9are. 200*? 2$4143$61444.
Transcriptomic and Proteomic Analysis of Potential Therapeutic Target Genes in The Liver of Metformin Treated Sprague Dawley Rats With Type 2 Diabetes Mellitusijmm-41!06!3327
A Study To Assess The Effectiveness of Selected Teaching Strategies Knowledge Regarding Drug Calculation Among B.Sc. N Students in Selected College at Chennai